Section 1: The Regulatory Compact: Establishing the Framework for Generic Drugs The modern pharmaceutical landscape, characterized by the widespread availability […]
Are Generic Drugs Less Safe than their Branded Equivalents? Read Post »
Executive Summary This report provides a comprehensive primer on drug patents, emphasizing their indispensable role as strategic assets in the
A Comprehensive Primer on Drug Patents for Competitive Advantage Read Post »
Emerging markets are the primary growth engines for the global pharmaceutical industry, particularly for generic drugs, driven by substantial patent
Finding Generic Drug Entry Opportunities in Emerging Markets Read Post »
Introduction: The $3 Trillion Tightrope Walk The global pharmaceutical market is a behemoth, an economic force of staggering proportions. Valued
How to Order the FDA Orange Book Historical copies of the FDA Orange Book archives are very potent tools for
Download FDA Orange Book Archives Read Post »
1. Executive Summary This report provides a comprehensive analysis of Dupixent’s (dupilumab) pricing model to assess its viability as a
How a $37,000-a-year medicine sets a good model for drug pricing Read Post »
The pharmaceutical industry is a high-stakes arena, where innovation isn’t just a buzzword – it’s the lifeblood of progress, patient
3 big mistakes drug companies make in recruiting new employees Read Post »
The pharmaceutical industry stands at a historic inflection point. For decades, it has operated on a simple, wildly profitable playbook:
Executive Summary & The New Biologic Battleground The global pharmaceutical landscape is undergoing a seismic shift, driven by the confluence
The Biosimilar Gambit: Turning Patent Expirations into Market Dominance Read Post »
Get fresh news and insights, drug patent expirations & more…
